Juvenile idiopathic arthritis Musculoskeletal Diseases Juvenile arthritis
Conditions
Interventions
The trial will comprise of a literature review, a prospective study to collect observational data (to inform a possible future RCT), a survey of healthcare professionals on current practice, qualitati
Sponsors
Alder Hey Children’s Foundation NHS Trust (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with JIA and their parents/carers will be eligible to take part in the qualitative research aspect of the trial
Exclusion criteria
Exclusion criteria: Patients aged under 8 years and patients/carers residing more that one days' travel away from the primary research site (Liverpool)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Develop outcomes of the feasibility study including a report to HTA with assessment of the proposed intervention and control arms for definitive study | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. A comprehensive assessment of current UK practice as regards JIA CS treatment, and potential trial capability and acceptability (by conducting a national survey) 2. Ascertainment of HCP views on the most appropriate patient group(s) and control and intervention arms (through a stakeholder consensus meeting) 3. A qualitative study of parent and patient perspectives in relation to a future RCT of CS 4. The choice of a primary outcome measure for a clinical trial in children and young people with JIA (through literature review, Delphi process and stakeholder consensus meeting) 5. Undertake a prospective feasibility study for the early induction of remission in children and young people with JIA testing chosen primary outcome, treatment arms and JIA subgroups to be studied | — |
Countries
United Kingdom
Outcome results
None listed